The Human Neonatal Rotavirus Vaccine (RV3-BB) Targeting Rotavirus from Birth: from discovery to the development of a vaccine for the world’s children

Rotavirus is a major cause of death and disease in children worldwide. Despite clear evidence of the success of rotavirus vaccines, barriers remain to global implementation with over 94 million children still lacking access to a rotavirus vaccine. These barriers include sub-optimal efficacy in low-income settings, lingering safety concerns and cost. Administering a vaccine at birth has the potential to address these challenges. 

What affects child development during the first 1000 days? Evidence and implications

This presentation focuses on the earliest stages of child development: the period from conception to the end of the child’s second year – known as the first 1000 days. A growing body of evidence shows that experiences during this period can have life-long consequences for health and wellbeing. The presentation is based on research for the “Strong Foundations” project and an evidence paper “Getting it right in the first 1000 days”. 

What if we asked the public? Innovations & Impact with the U.S. National Poll on Children’s Health

This is an effort to bring the public voice about children’s health into national dialogue and health policy. Using a twin-track approach of online media (open-access monthly Reports) and traditional peer-reviewed journal publications, Matthew and his colleagues have brought the perceptions and opinions of parents and others into the international conversation about children’s illness and health and how policymaking can play a role.

Responding in a medical context to the effects of family violence on children

There is growing evidence of the health effects caused by family violence ranging from fatal (homicide, suicide, maternal mortality) to non-fatal (physical health, mental health, chronic conditions, reproductive health issues, and negative health behaviours). Negative impacts of family violence on children are wide ranging and profound.

The roadmap for childhood tuberculosis: paediatricians and programmes

This talk will provide background of where tuberculosis fits into the context of the child survival agenda as well as the global tuberculosis control challenges. It will review the main challenges, both the need to do much better with what we have and the need for new and innovative tools particularly in diagnostics.

A special RCH Grand Rounds

The Grand Round will be part history, science, personal reflections, a tribute to patients and their families, and the multidisciplinary teams involved in their care at RCH over the last 40 years.